AM_GEHC_WOM-Logo

Breast

ECR: LLMs help patients understand breast imaging reports
By Amerigo Allegretto
Hemal Grover, MD, shared results from two studies of how LLMs can improve report readability for patients.
March 6, 2026
Ecr 2026 Welcome Thumbnail
Lancet Oncology: Global breast cancer cases could surge to 3.5M by 2050
By Kate Madden Yee
The study also found that yearly deaths could increase by 44%, climbing from 764,000 in 2023 to nearly 1.4 million in 2050.
March 2, 2026
Graph Arrow Up
Media reporting overlooks parts of breast cancer screening guidelines
By Amerigo Allegretto
News media did not often address some parts of the U.S. Preventive Services Task Force's updated breast cancer screening guidelines.
March 2, 2026
Breast Self Exam2 400
AI support leads to more cancers found on DBT
By Amerigo Allegretto
AI assistance for interpreting screening DBT exams led to sharp increases in finding invasive and lobular cancers.
February 23, 2026
Breast Dbt 400
Mammography screening improves survival for late-stage cancers
By Amerigo Allegretto
Women with screen-detected late-stage cancer have greater survival compared with women who do not undergo mammography screening.
February 20, 2026
Mammo Reading 400
OncoRes secures $19M on path to U.S. trial
By AuntMinnie.com staff writers
The funds will support clinical development and regulatory milestones for OncoRes' quantitative micro‑elastography imaging system.
February 13, 2026
Business Graph Money Stocks
Women's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1
By Amerigo Allegretto
Vilert Loving, MD, from Ochsner Health and the SBI discusses breast cancer screening based on annual mammography versus risk.
February 13, 2026
Minnie Cast Thumbnail (1) 1
Could AI scoring help with managing DCIS?
By Amerigo Allegretto
An AI model showed associations with recurrence after DCIS surgery and performed comparably to established clinical risk models.
February 11, 2026
Images of a 39-year-old who underwent screening mammography. Right craniocaudal (left) and mediolateral oblique (middle) views from preoperative mammography show suspicious grouped fine pleomorphic calcifications (arrows). After biopsy showed ductal carcinoma of situ (DCIS), patient underwent breast-conserving surgery, yielding final diagnosis of ductal carcinoma in situ (intermediate grade, hormone receptor positive). (Right) Screenshot of an output of a commercial AI tool applied to preoperative mammography. AI detected right breast lesion with score of 95% on both views (concentric colored circles). Present study’s reviewing radiologist deemed AI marking to correspond with site of DCIS.
Nonsurgical management rising for low-risk DCIS cases
By Amerigo Allegretto
Trends show that nonsurgical management of DCIS is rising, paving the way for imaging's role in active surveillance.
February 10, 2026
Breast Mammo 400
DBT-guided biopsies show practical advantages
By Amerigo Allegretto
New research says DBT-guided biopsies lead to less procedure times and radiation exposure compared to mammography-guided biopsies.
February 9, 2026
Breast Dbt Social
Could CEUS improve BI-RADS assessment?
By Amerigo Allegretto
Adding Contrast-enhanced ultrasound (CEUS) to BI-RADS could help improve classification of breast lesions.
February 6, 2026
Contrast Injector
Breast MRI with half-dose gadopiclenol comparable to gadobutrol exams
By Kate Madden Yee
The results are particularly good news for patients who require repeated MR imaging.
February 5, 2026
Mri Breast Cancer
Page 1 of 579
Next Page